Literature DB >> 31482410

Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma.

Jong Man Kim1, Jae-Won Joh2, Nam-Joon Yi3, Gyu-Seong Choi1, Kyunga Kim4, Kwang-Woong Lee3, Kyung-Suk Suh3.   

Abstract

BACKGROUND AND
PURPOSE: Several hepatectomy patients with HCC who are initially transplantable (within MC) developed untransplantable HCC recurrence (beyond MC) after primary curative liver resection. The purpose of our study is to identify the risk factors of untransplantable hepatocellular carcinoma (HCC) recurrence after primary curative resection of solitary HCC and solitary HCC within Milan criteria (MC).
METHODS: We retrospectively reviewed 592 patients with recurrent HCC who underwent liver resection due to solitary HCC between 2005 and 2011.
RESULTS: All patients were Child-Pugh class A. At primary curative hepatectomy, 411 patients (69.4%) were diagnosed with HCC within MC and 181 patients (30.6%) had HCC beyond MC. The mean time from primary hepatectomy to recurrence was 14 months (range, 1-116 months). At HCC recurrence, 93 patients (15.7%) were diagnosed beyond MC. Multivariate analysis showed that microvascular invasion and a tumor grade of 3 or 4 were closely associated with a high risk of HCC recurrence beyond MC in patients who had hepatectomy for solitary HCC. Of the 411 patients within MC at primary curative hepatectomy, 54 patients (13.9%) developed HCC recurrence beyond MC. Multivariate analysis also showed that microvascular invasion and a tumor grade of 3 or 4 were closely associated with HCC recurrence beyond MC in these patients.
CONCLUSIONS: The present study suggests that the presence of certain unfavorable histological factors in patients who underwent initial liver resection of transplantable HCC within MC with good liver function predicted the development of recurrent HCC beyond MC.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Liver transplantation; Milan criteria; Tumor recurrence

Mesh:

Year:  2019        PMID: 31482410     DOI: 10.1007/s11605-019-04363-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  2 in total

1.  Inhibition of long noncoding RNA cancer susceptibility candidate 7 attenuates hepatocellular carcinoma development by targeting microRNA-30a-5p.

Authors:  Dongsheng Li; Lin Lu; Miaomiao Liu; Jufeng Sun
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

2.  Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.

Authors:  Lidi Ma; Kan Deng; Cheng Zhang; Haixia Li; Yingwei Luo; Yingsi Yang; Congrui Li; Xinming Li; Zhijun Geng; Chuanmiao Xie
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.